Related Experiment Video
Updated: May 30, 2026
09:04
Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Nucleic acid therapy for lifespan prolongation: present and future
1Department of Chemistry, The University of Hong Kong, Hong Kong Special Administrative Region, China. rori0610@graduate.hku.hk
Journal of Biosciences
|August 23, 2011
Summary
Scientists are exploring nucleic acid therapy to extend human lifespan. While the theory is developing, practical anti-aging applications are limited, highlighting a need for more research into gene-longevity links.
Area of Science:
- Biotechnology
- Genetics
- Gerontology
Background:
- Humanity has a long-standing desire for lifespan extension.
- Advances in biotechnology are revealing aging mechanisms.
- Nucleic acid therapy offers a theoretical basis for longevity interventions.
Purpose of the Study:
- To review the relationship between genes and longevity.
- To explore the potential of nucleic acid therapy for lifespan prolongation.
- To bridge the gap between aging theory and clinical application.
Main Methods:
- Literature review of scientific databases (PubMed, Web of Science).
- Analysis of studies published between 2000-2010 focusing on nucleic acid therapy for anti-aging and longevity.
- Synthesis of current understanding of gene-longevity associations.
Main Results:
- A limited number of studies (seven) directly addressed nucleic acid therapy for anti-aging between 2000-2010.
- The theoretical framework for nucleic acid therapy in lifespan extension is developing.
- Clinical translation of nucleic acid therapy for longevity remains inadequately addressed.
Conclusions:
- There is a significant gap between the theoretical potential of nucleic acid therapy and its clinical application for lifespan prolongation.
- Further research is needed to convert theoretical knowledge into practical anti-aging interventions.
- Understanding the genetic basis of longevity is crucial for developing effective nucleic acid-based therapies.
Related Concept Videos
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
03:00Next-generation Sequencing
The first human genome sequencing project cost $2.7 billion and was declared complete in 2003, after 15 years of international cooperation and collaboration between several research teams and funding agencies. Today, with the advent of next-generation sequencing technologies, the cost and time of sequencing a human genome have dropped over 100 fold.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...